News and Trends 7 Oct 2016
Meet the ‘Haut-Couturiers’ of Bioengineering
It's time to ride the slopes and land in the French alpine capital, Grenoble, to meet our Biotech of the week, BGene Genetics. This start-up is changing the bug factory…
Jerome Topsent
About
Business Development Manager. PharmD specialized in Biotechnology and advanced therapies. I love to highlight the great discoveries that are made every day in Biotech, ranging from monoclonal antibodies to biofuel.
Articles by Jerome Topsent
News and Trends 26 Sep 2016
A Colony from a single-cell? All possible with Takara Bio
Induced pluripotent stem cells were discovered back in 2006. Since then, they have become a valuable new source of pluripotent cells for research and therapy. And thanks to gene editing technologies,…
News and Trends 9 Sep 2016
How to get Antibiotic free Bioproduction in Biotech with Delphi Genetics
After Vienna, it's time to jump in the middle of the Paris-Amsterdam-Frankfurt triangle in the BioPark of Brussels South in Belgium. We will meet a company who can answer the…
News and Trends 5 Sep 2016
NanoTemper: the Game-changer for Drug Development Technologies
“Getting better drugs faster” is what biochemist Dr. Stefan Duhr and biophysicist Dr. Philipp Baaske envisioned when they started building NanoTemper Technologies. Established in 2008 in Munich, NanoTemper Technologies provides innovative solutions to…
ADVERTISEMENT
News and Trends 6 Jul 2016
This company ensures quality DNA suitable for Clinical applications from demanding Human body fluid Samples
For today’s sensitive clinical genetic testing applications, making a fast and affordable isolation of high-quality nucleic acids from whole blood or plasma samples is a key bottleneck. But hey, here is…
News and Trends 27 Jun 2016
Genticel is facing hard Times Again!
As presented last week, Genticel was getting back on track with the announcement of two major milestones with the aim to prepare the phase III. However, the major outcomes of…
ADVERTISEMENT
News and Trends 23 Jun 2016
Cellectis gets paid for a first Milestone, Investors are pleased
After successfully 'saving' two babies with terminal-stage acute Leukemia, Cellectis finally treated the first patient in its Phase I trial. A major milestone that could confirm the potential of its…
News and Trends 17 Jun 2016
After its drop earlier this year, Genticel goes back up the slope
Genticel has announced that not one but two milestones have been achieved in the development of its products, which focus on immunotherapies for cancers caused by the human papillomavirus. Genticel…
News and Trends 17 Jun 2016
Apogenix’s lead Candidate has more than one Trick up its Sleeve
Apogenix's lead candidate APG101, which has shown great results in a phase II study to treat Glioblastoma, has a new target in line. But this time, it's not against cancer...…
News and Trends 14 Jun 2016
Unlock the power of Text-mining tools
It has become clear that text mining is a great tool for rapid analysis of large volumes of biomedical literature. It delivers valuable information that helps to improve the accuracy and…
News and Trends 30 May 2016
Besides Techno, Berlin is also the place to be for Life Science Industries
On the 25th of May, the largest network event for life sciences and healthcare industries in the German capital region once again came to life for the 14th time, for Bionnale 2016 . As…
News and Trends 12 Apr 2016
How CAR-T Cells Kill Cancer: Pictures start Moving
CAR-T is a groundbreaking personalized cancer therapy with tremendous potential to drive the patient’s own immune cells to specifically target and kill cancer cells. Because the development of this therapy…